Document:

ex10-3.htm

    
    
        
             
        

    

    CareView Communications, Inc. 8-K

    
        Exhibit 10.3
    

    
         
    

    
        AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT
    

    
         
    

    
        THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of February 2, 2018 by and between CareView Communications, Inc., a Nevada corporation (the “Company”) and PDL Investment Holdings, LLC (as assignee of PDL BioPharma, Inc.), a Delaware limited liability company (the “Original Holder”).
    

    
         
    

    
        RECITALS
    

    
         
    

    
        A.          The Company, certain subsidiaries and the Original Holder have entered into a Credit Agreement dated as of June 26, 2015, as amended by that certain First Amendment to Credit Agreement, dated as of October 7, 2015, pursuant to which the Original Holder has agreed to lend to the Company up to Forty Million Dollars ($40,000,000.00) on the terms and conditions set forth therein (as amended, the “Credit Agreement”).
    

    
         
    

    
        B.          The Company, certain subsidiaries and the Original Holder have entered into a Modification Agreement dated as of the date hereof (the “Modification Agreement”) in connection with the Original Holder’s agreement to modify on the terms set forth therein certain provisions of the Credit Agreement and certain other loan documents in respect of Covered Events (as defined in the Modification Agreement).
    

    
         
    

    
        C.          Pursuant to the Credit Agreement and the Modification Agreement, the Company has issued to the Original Holder a Second Amended and Restated Warrant dated as of the date hereof (the “Warrant”), pursuant to which the Original Holder and its assignees have the right to acquire shares of common stock, par value $0.001 per share, of the Company.
    

    
         
    

    
        D.          In connection with the execution and delivery of the Credit Agreement, the Modification Agreement and the Warrant and the consummation of the transactions contemplated thereby, the Company has agreed to grant the Original Holder certain registration rights as set forth below.
    

    
         
    

    
        E.          This Amended and Restated Registration Rights Agreement amends and restates in its entirety that certain Registration Rights Agreement by and between the Company and the Original Holder, dated as of June 26, 2015.
    

    
         
    

    
        AGREEMENT
    

    
         
    

    
        In consideration of the foregoing and the mutual covenants and agreements herein contained, and intending to be legally bound hereby, the parties agree as follows:
    

    
         
    

    
        Article I
        
            
 DEFINITIONS
    

    
         
    

    
        Section 1.1     
        Certain Definitions. As used in this Agreement, capitalized terms not otherwise defined herein shall have the meanings ascribed to them below:
    

    
         
    

    
        “Business Day” means any day that is not a Saturday, a Sunday or other day on which banks are required or authorized by law to be closed in The City of New York.
    

    
         
    

    
    
        

    

    
         

    

    
    
         
    

    
        “Common Stock” means the common stock, par value $0.001 per share, of the Company, and any equity securities issued or issuable in exchange for or with respect to the Common Stock by way of a stock dividend, stock split or combination of shares or in connection with a reclassification, recapitalization, merger, consolidation or other reorganization or otherwise.
    

    
         
    

    
        “Common Stock Equivalent” means all options, warrants and other securities convertible into, or exchangeable or exercisable for (at any time or upon the occurrence of any event or contingency and without regard to any vesting or other conditions to which such securities may be subject), Common Stock.
    

    
         
    

    
        “Designated Holder” means the Original Holder or, if the Original Holder no longer holds more than 10% of the then outstanding Registrable Securities, Participating Holders holding more than 50% of the then outstanding Registrable Securities.
    

    
         
    

    
        “Effectiveness Period” means the period from the date hereof until such date as the Holders no longer hold any Registrable Securities.
    

    
         
    

    
        “Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.
    

    
         
    

    
        “FINRA” means the Financial Industry Regulatory Authority, Inc.
    

    
         
    

    
        “HealthCor Holder” means those holders of the Company’s securities party to the HealthCor Registration Rights Agreement.
    

    
         
    

    
        “HealthCor Registration Rights Agreement” means that certain registration rights agreement dated April 21, 2011, by and among the Company, HealthCor Partners Fund, L.P., HealthCor Hybrid Offshore Master Fund, L.P. and the other investors party thereto, as amended, supplemented or modified from time to time.
    

    
         
    

    
        “HealthCor Registrable Securities” shall have the same meaning as “Registrable Securities” as defined in the HealthCor Registration Rights Agreement.
    

    
         
    

    
        “Holder” or “Holders” means the Original Holder and any Person who shall acquire and hold Registrable Securities in accordance with the terms of this Agreement.
    

    
         
    

    
        “Issuer Free Writing Prospectus” means an issuer free writing prospectus, as defined in Rule 433 under the Securities Act, relating to an offer of Registrable Securities.
    

    
         
    

    
        “Participating Holders” has the meaning set forth in Section 2.1(a)(ii).
    

    
         
    

    
    
        
            2
            
        

    

    
         

    

    
    
         
    

    
        “Prospectus” means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 424(b) promulgated under the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of any portion of the Registrable Securities covered by the Registration Statement, and all other amendments and supplements to the Prospectus, including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in such Prospectus.
    

    
         
    

    
        “Person” means any individual, corporation, partnership, limited liability company, limited liability partnership, syndicate, person, trust, association, organization or other entity or any governmental or regulatory body or other agency or authority or political subdivision thereof, including any successor, by merger or otherwise, of any of the foregoing.
    

    
         
    

    
        “Registrable Securities” means the Warrant Shares, any other securities issued or issuable upon exercise of the Warrant and any other securities issued or issuable with respect to or in exchange for any such securities, provided such securities shall cease to be Registrable Securities when: (i) sold pursuant to an effective registration statement or sold pursuant to Rule 144 or any successor provision under the Securities Act; or (ii) such security becomes eligible for sale without restriction by the applicable Holder pursuant to and in compliance with Rule 144 or any successor provision under the Securities Act.
    

    
         
    

    
        “Registration Expenses” means all fees and expenses incurred in connection with the Company’s performance of or compliance with the provisions of Article II, including: (i) all registration, listing, qualification and filing fees (including FINRA filing fees); (ii) fees and expenses of compliance with state securities or “blue sky” laws (including counsel fees in connection with the preparation of a blue sky and legal investment survey and FINRA filings); (iii) printing and copying expenses; (iv) messenger and delivery expenses; (v) expenses incurred in connection with any road show; (vi) fees and disbursements of counsel for the Company; (vii) with respect to each registration, the reasonable fees and disbursements of one counsel for the selling Holder(s) selected by the Designated Holder and reasonably satisfactory to the Company, in the case of a registration pursuant to Section 2.1, and selected by the underwriter and reasonably satisfactory to the Designated Holder, in the case of a registration pursuant to Section 2.2; (viii) fees and disbursements of independent public accountants, including the expenses of any audit or “cold comfort” letter, and fees and expenses of other persons, including special experts, retained by the Company; (ix) underwriter fees, excluding discounts and commissions, and any other expenses which are customarily borne by the issuer or seller of securities in a public equity offering; and (x) all internal expenses of the Company (including all salaries and expenses of officers and employees performing legal or accounting duties).
    

    
         
    

    
        “Registration Statement” means any registration statement required to be filed under this Agreement, including the Prospectus, amendments and supplements to such registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material incorporated by reference or deemed to be incorporated by reference in such registration statement.
    

    
         
    

    
    
        
            3
            
        

    

    
         

    

    
    
         
    

    
        “SEC” means the Securities and Exchange Commission.
    

    
         
    

    
        “Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.
    

    
         
    

    
        “Warrant Shares” means the shares of Common Stock issuable upon the exercise of the Warrant.
    

    
         
    

    
        Article II
        
            
 REGISTRATION RIGHTS
    

    
         
    

    
        Section 2.1     
        Demand Registrations.
    

    
         
    

    
        (a)          
        (i)        Subject to Section 2.1(c), at any time following the date hereof but prior to the expiration of the Effectiveness Period, the Designated Holder shall have the right to require the Company to file a registration statement under the Securities Act covering Registrable Securities by delivering a written request therefor to the Company specifying the number of Registrable Securities to be included in such registration and the intended method of distribution thereof. All such requests by any Holder pursuant to this Section 2.1(a)(i) are referred to as “Demand Registration Requests,” the registrations so requested are referred to as “Demand Registrations” and the Holders making such demand for registration are referred to as the “Initiating Holders.” As promptly as practicable, but no later than 10 days after receipt of a Demand Registration Request, the Company shall give written notice (a “Demand Exercise Notice”) of such Demand Registration Request to all Holders of record of Registrable Securities other than the Initiating Holders.
    

    
         
    

    
        (ii)       
        The Company, subject to Sections 2.3 and 2.6, shall include in a Demand Registration (A) the Registrable Securities of the Initiating Holders and (B) the Registrable Securities of any other Holder of Registrable Securities that shall have made a written request to the Company within the time limits specified below for inclusion in such registration (together with the Initiating Holders, the “Participating Holders”). Any such request from the other Holders must be delivered to the Company within 15 days after the receipt of the Demand Exercise Notice and must specify the maximum number of Registrable Securities intended to be disposed of by such other Holders.
    

    
         
    

    
        (b)          
        (i)       The Company shall as soon as practicable (and in the case of an offering to be made on a continuous basis under Rule 415, in no event later than thirty (30) days following the Demand Registration Request) cause to be prepared and filed with the SEC a Registration Statement providing for the resale of all Registrable Securities which Holders request to be registered. The Registration Statement shall be on Form S-3 if the Company is then eligible to register for resale the Registrable Securities on such form (a “Short Form Registration”). If the Company is not then eligible to register for resale the Registrable Securities on Form S-3, such registration shall be on Form S-1 or another appropriate form in accordance herewith (a “Long Form Registration”).
    

    
         
    

    
        (ii)       
        The Company shall cause the Registration Statement to be declared effective under the Securities Act as promptly as possible after the filing thereof (and in the case of an offering to be made on a continuous basis under Rule 415, in no event later than either of (A) 180 calendar days following the date of the Demand Registration Request or (B) five Business Days following notification by the staff of the SEC to the Company that there will be no review of the Registration Statement or, if comments have been given, that the staff will have no further comments with respect thereto). The Company shall keep the Registration Statement continuously effective under the Securities Act until the date when all Registrable Securities covered by such Registration Statement have been sold.
    

    
         
    

    
    
        
            4
            
        

    

    
         

    

    
    
         
    

    
        (c)          
        The Demand Registration rights granted in Section 2.1(a) to the Holders are subject to the following limitations:
    

    
         
    

    
        (i)        
        the Company shall not be required to cause a registration pursuant to Section 2.1(a) to be filed within 90 days or to be declared effective within a period of 180 days after the effective date of any other registration statement of the Company filed pursuant to the Securities Act;
    

    
         
    

    
        (ii)       
        if the Company delivers to the Initiating Holders a certificate signed by the Company’s chief executive officer stating that, in the good faith judgment of the Company’s Board of Directors: (x) the registration could reasonably be expected to materially interfere with an acquisition, corporate reorganization or other material transaction then under consideration by the Company or (y) there is some other material development relating to the operations or condition (financial or other) of the Company that has not been disclosed to the general public and as to which it is in the Company’s best interests not to disclose (each of (x) and (y), a “Valid Business Reason”), the Company may postpone or withdraw a filing of a registration statement relating to a Demand Registration Request until such Valid Business Reason no longer exists, but in no event shall the Company avail itself of such right for more than 60 days (unless the Holders of at least a majority of the Registrable Securities consent in writing to a longer delay of up to an additional 30 days) in any period of 365 consecutive days (such period of postponement or withdrawal under this clause (ii), the “Postponement Period”); and the Company shall give notice of its determination to postpone or withdraw a registration statement and of the fact that the Valid Business Reason for such postponement or withdrawal no longer exists, in each case, promptly after the occurrence thereof;
    

    
         
    

    
        (iii)      
        The Company shall not be obligated to effect more than three Long Form Registrations. There shall be no limitation on the number of Short Form Registrations under Section 2.1(a); and
    

    
         
    

    
        (iv)      
        Notwithstanding any provision of this Agreement to the contrary, neither the Designated Holder nor any other Holder shall have any right under this Agreement to require that a distribution of Registrable Securities be effected by means of an underwriting.
    

    
         
    

    
        If the Company shall give any notice of postponement or withdrawal of any registration statement pursuant to clause (ii) above, the Company shall not register any equity security of the Company during the period of postponement or withdrawal. Each Holder of Registrable Securities agrees that, upon receipt of any notice from the Company that the Company has determined to withdraw any registration statement pursuant to clause (ii) above, such Holder will discontinue its disposition of Registrable Securities pursuant to such registration statement. If the Company shall have withdrawn or prematurely terminated a registration statement filed under Section 2.1(a)(i), the Company shall not be considered to have effected an effective registration for the purposes of this Agreement until the Company shall have filed a new registration statement covering the Registrable Securities covered by the withdrawn registration statement and such registration statement shall have been declared effective and shall not have been withdrawn. If the Company shall give any notice of withdrawal or postponement of a registration statement, at such time as the Valid Business Reason that caused such withdrawal or postponement no longer exists (but in no event more than 60 days, or, with the written consent of the Holders of at least a majority of the Registrable Securities, 90 
        days, after the date of the postponement or withdrawal), the Company shall use its commercially reasonable efforts to effect the registration under the Securities Act of the Registrable Securities covered by the withdrawn or postponed registration statement in accordance with this Section 2.1.
    

    
         
    

    
    
        
            5
            
        

    

    
         

    

    
    
          
    

    
        (d)           
        A Holder may withdraw its Registrable Securities from a Demand Registration at any time. If all such Holders do so, the Company shall cease all efforts to secure registration and such registration nonetheless shall be deemed a Demand Registration for purposes of this Section 2.1 unless (i) the withdrawal is made following withdrawal or postponement of such registration by the Company pursuant to a Valid Business Reason as contemplated by Section 2.1(c), (ii) the withdrawal is based on the reasonable determination of the Holders who requested such registration that there has been, since the date of the Demand Registration Request, a material adverse change in the business or prospects of the Company or (iii) the Holders who requested such registration shall have paid or reimbursed the Company for all of the reasonable out-of-pocket fees and expenses incurred by the Company in connection with the withdrawn registration.
    

    
         
    

    
        (e)           
        A Demand Registration shall not be deemed to have been effected and shall not count as such (i) unless a registration statement with respect thereto has become effective and has remained effective for a period of at least 180 days or such shorter period during which all Registrable Securities covered by such Registration Statement have been sold or withdrawn, (ii) if, after the registration statement with respect thereto has become effective, it becomes subject to any stop order, injunction or other order or requirement of the SEC or other governmental agency or court for any reason, or (iii) if it is withdrawn by the Company pursuant to a Valid Business Reason as contemplated by Section 2.1(c).
    

    
         
    

    
        Section 2.2     
        Piggyback Registrations.
    

    
         
    

    
        (a)           
        If at any time during the Effectiveness Period, the Company shall determine to register any of its equity securities under the Securities Act (other than pursuant to (i) registrations on such form or similar form(s) solely for registration of securities in connection with an employee benefit plan or dividend reinvestment plan or (ii) a Demand Registration under Section 2.1) on a registration statement on Form S-1 or Form S-3 or an equivalent general registration form then in effect (but excluding any registration statement on Form S-4 or Form S-8), whether or not for its own account, the Company shall give prompt written notice of its intention to do so to each Holder of record of Registrable Securities. Upon the written request of any such Holder, made within 15 days following the receipt of any such written notice (which request shall specify the maximum number of Registrable Securities intended to be disposed of by such Holder and the intended method of distribution thereof), the Company, subject to Sections 2.2(b), 2.3 and 2.6, shall use commercially reasonable efforts to cause all such Registrable Securities to be included in the registration statement with the securities that the Company at the time proposes to register to permit the sale or other disposition by the Holders in accordance with the intended method of distribution thereof of the Registrable Securities to be so registered. No registration of Registrable Securities effected under this Section 2.2(a) shall relieve the Company of its obligations to effect Demand Registrations under Section 2.1.
    

    
         
    

    
    
        
            6
            
        

    

    
         

    

    
    
         
    

    
        (b)           
        If, at any time after giving written notice of its determination to register any equity securities and prior to the effective date of the registration statement filed in connection with such registration, the Company shall determine for any reason not to register or to delay registration of such equity securities, the Company will give written notice of such determination to each Holder of record of Registrable Securities and (i) in the case of a determination not to register, shall be relieved of its obligation to register any Registrable Securities in connection with such abandoned registration, without prejudice, however, to the rights of Holders under Section 2.1 and (ii) in the case of a determination to delay such registration of its equity securities, shall be permitted to delay the registration of such Registrable Securities for the same period as the delay in registering such other equity securities.
    

    
         
    

    
        (c)           
        Any Holder shall have the right to withdraw its request for inclusion of its Registrable Securities in any registration statement pursuant to this Section 2.2 by giving written notice to the Company of its request to withdraw. Such request must be made in writing prior to the earlier of (i) the use by the Company or any underwriters of any preliminary prospectus or preliminary prospectus supplement that is part of such registration statement, (ii) the execution of the underwriting agreement with respect to such registration or (iii) the execution of the custody agreement with respect to such registration. Such withdrawal shall be irrevocable and, after making such withdrawal, a Holder shall no longer have any right to include Registrable Securities in the registration as to which such withdrawal was made.
    

    
         
    

    
        Section 2.3     
        Priority in Registrations.
    

    
         
    

    
        (a)           
        If any registration pursuant to Section 2.2 involves an underwritten offering that is proposed by the Company and the lead managing underwriter of such offering (the “Manager”) shall advise the Company that, in its view, the aggregate number of securities requested to be included in such registration by the Company, the Holders and the holders of securities of the Company, including the HealthCor Holders, that have the right to require such registration pursuant to an agreement entered into by the Company (“Additional Registration Rights”) exceeds the number (the “Section 2.3(a) Sale Number”) that can be sold in an orderly manner in such registration within a price range acceptable to the Company (such difference, the “Aggregate Underwriter Cutback”), the Company shall include in such registration: (i) all Common Stock that the Company proposes to register for its own account less such number of shares equal to 50% of the Aggregate Underwriter Cutback (such number of shares to be registered, the “Company Allotment”), and (ii) the aggregate of all Registrable Securities and all HealthCor Registrable Securities for which the Holders and the HealthCor Holders, respectively, request registration (such number of securities, the “Aggregate Registration Request”) less such number of securities equal to 50% of the Aggregate Underwriter Cutback (such number of securities to be registered, the “Registrable Securities Allotment”). To the extent that the Aggregate Registration Request exceeds the Registrable Securities Allotment, the securities to be included in the Registrable Securities Allotment shall be allocated on a pro rata basis among (i) all Holders requesting that Registrable Securities be included in such registration pursuant to the exercise of piggyback rights pursuant to Section 2.2 of this Agreement and (ii) all HealthCor Holders requesting that HealthCor Registrable Securities be included in such registration, based on the number of (x) Registrable Securities that each such Holder is then requesting for inclusion and (y) HealthCor Registrable Securities that each such HealthCor Holder is then requesting for inclusion, which, together with the Company Allotment, shall not exceed the Section 2.3(a) Sale Number.
    

    
         
    

    
    
        
            7
            
        

    

    
         

    

    
    
         
    

    
        (b)           
        If any registration pursuant to Section 2.2 involves an underwritten offering that was proposed by the HealthCor Holders or other holders of Additional Registration Rights and the Manager shall advise the Company that, in its view, the number of securities requested to be included in such registration exceeds the number (the “Section 2.3(b) Sale Number”) that can be sold in an orderly manner in such registration within a price range acceptable to the Company, the securities to be included in such registration shall be allocated by the Company first, on a pro rata basis among (i) all Holders requesting that Registrable Securities be included in such registration pursuant to the exercise of piggyback rights pursuant to Section 2.2 of this Agreement and (ii) all HealthCor Holders requesting the inclusion in such registration of HealthCor Registrable Securities, based on the number of (x) Registrable Securities that each such Holder is then requesting for inclusion and (y) HealthCor Registrable Securities that each such HealthCor Holder is requesting for inclusion, which shall not exceed the Section 2.3(b) Sale Number, and second, to the other holders of Additional Registration Rights (if any).
    

    
         
    

    
        Section 2.4       
        Registration Procedures. Whenever the Company is required by the provisions of this Agreement to use commercially reasonable efforts to effect or cause the registration of any Registrable Securities under the Securities Act as provided in this Agreement, the Company as expeditiously as possible:
    

    
         
    

    
        (a)           
        shall prepare and file with the SEC the requisite Registration Statement, which shall comply as to form in all material respects with the requirements of the applicable form and shall include all financial statements required by the SEC to be filed therewith, and use commercially reasonable efforts to cause such Registration Statement to become and remain effective (provided, however, that before filing a Registration Statement or Prospectus or any amendments or supplements thereto, or comparable statements under securities or blue sky laws of any jurisdiction, or any Issuer Free Writing Prospectus related thereto, the Company will furnish to one counsel for the Holders participating in the planned offering (selected by the Designated Holder and reasonably satisfactory to the Company, in the case of a registration pursuant to Section 2.1, and selected by the lead managing underwriter, if any, and reasonably satisfactory to the Designated Holder, in the case of a registration pursuant to Section 2.2) and the lead managing underwriter, if any, copies of all such documents proposed to be filed (including all exhibits thereto), which documents will be subject to the reasonable review and reasonable comment of such counsel, and the Company shall not file any Registration Statement or amendment thereto, any Prospectus or supplement thereto or any Issuer Free Writing Prospectus related thereto to which the Designated Holder covered by such Registration Statement or the underwriters, if any, shall reasonably object);
    

    
         
    

    
    
        
            8
            
        

    

    
         

    

    
    
         
    

    
        (b)         
        shall prepare and file with the SEC such amendments and supplements to such Registration Statement and the Prospectus used in connection therewith as may be necessary to keep such Registration Statement effective for such period as any seller of Registrable Securities pursuant to such Registration Statement shall request and to comply with the provisions of the Securities Act with respect to the sale or other disposition of all Registrable Securities covered by such Registration Statement in accordance with the intended methods of disposition by the seller or sellers thereof set forth in such Registration Statement;
    

    
         
    

    
        (c)          
        shall furnish, without charge, to each seller of such Registrable Securities and each underwriter, if any, of the securities covered by such Registration Statement such number of copies of such Registration Statement, each amendment thereto, the Prospectus included in such Registration Statement, each preliminary Prospectus and each Issuer Free Writing Prospectus utilized in connection therewith, all in conformity with the requirements of the Securities Act, and such other documents as such seller and underwriter may reasonably request in order to facilitate the public sale or other disposition of the Registrable Securities owned by such seller, and shall consent to the use in accordance with all applicable law of each such Registration Statement, each amendment thereto, each such Prospectus, preliminary Prospectus or Issuer Free Writing Prospectus by each such seller of Registrable Securities and the underwriters, if any, in connection with the offering and sale of the Registrable Securities covered by such Registration Statement or Prospectus;
    

    
         
    

    
        (d)          
        shall use commercially reasonable efforts to register or qualify the Registrable Securities covered by such Registration Statement under such other securities or “blue sky” laws of such jurisdictions as any sellers of Registrable Securities or any managing underwriter, if any, reasonably shall request, and do any and all other acts and things that may be reasonably necessary or advisable to enable such sellers or underwriter, if any, to consummate the disposition of the Registrable Securities in such jurisdictions, except that in no event shall the Company be required to qualify to do business as a foreign corporation in any jurisdiction where, but for the requirements of this Section 2.4(d), it would not be required to be so qualified, to subject itself to taxation in any such jurisdiction or to consent to general service of process in any such jurisdiction;
    

    
         
    

    
        (e)          
        shall promptly notify each Holder selling Registrable Securities covered by such Registration Statement and each managing underwriter, if any:
    

    
         
    

    
        (i)       
        when the Registration Statement, any pre-effective amendment, the Prospectus or any Prospectus supplement related thereto, any post-effective amendment to the Registration Statement or any Issuer Free Writing Prospectus has been filed and, with respect to the Registration Statement or any post-effective amendment, when the same has become effective;
    

    
         
    

    
        (ii)      
        of any request by the SEC or state securities authority for amendments or supplements to the Registration Statement or the Prospectus related thereto or for additional information;
    

    
         
    

    
        (iii)     
        of the issuance by the SEC of any stop order suspending the effectiveness of the Registration Statement or the initiation of any proceedings for that purpose;
    

    
         
    

    
    
        
            9
            
        

    

    
         

    

    
    
         
    

    
        (iv)     
        of the receipt by the Company of any notification with respect to the suspension of the qualification of any Registrable Securities for sale under the securities or blue sky laws of any jurisdiction or the initiation of any proceeding for such purpose;
    

    
         
    

    
        (v)      
        of the existence of any fact of which the Company becomes aware which results in the Registration Statement, the prospectus related thereto, any document incorporated therein by reference, any Issuer Free Writing Prospectus or the information conveyed to any purchaser at the time of sale to such purchaser containing an untrue statement of a material fact or omitting to state a material fact required to be stated therein or necessary to make any statement therein not misleading; and
    

    
         
    

    
        (vi)     
        if at any time the representations and warranties contemplated by any underwriting agreement, securities sale agreement, or other similar agreement relating to the offering shall cease to be true and correct in all material respects; and, if the notification relates to an event described in clause (v), the Company, subject to the provisions of Section 2.1(c), promptly shall prepare and file with the SEC, and furnish to each seller and each underwriter, if any, a reasonable number of copies of, a Prospectus supplemented or amended so that, as thereafter delivered to the purchasers of such Registrable Securities, such Prospectus shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein in the light of the circumstances under which they were made not misleading;
    

    
         
    

    
        (f)          
        shall comply with all applicable rules and regulations of the SEC, and make generally available to its security holders, as soon as reasonably practicable after the effective date of the Registration Statement (and in any event within 90 days after the end of such 12 month period described hereafter), an earnings statement, which need not be audited, covering the period of at least 12 consecutive months beginning with the first day of the Company’s first calendar quarter after the effective date of the registration statement, which earnings statement shall satisfy the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder;
    

    
         
    

    
        (g)         
        shall cause all Registrable Securities covered by such Registration Statement to be authorized to be listed on a national securities exchange if shares of the particular class of Registrable Securities are at that time, or will be immediately following the offering, listed on such exchange;
    

    
         
    

    
        (h)         
        shall provide and cause to be maintained a transfer agent and registrar for all such Registrable Securities covered by such Registration Statement not later than the effective date of such Registration Statement;
    

    
         
    

    
        (i)          
        shall enter into such customary agreements (including, if applicable, an underwriting agreement) and take such other actions as the Designated Holder shall reasonably request in order to expedite or facilitate the disposition of such Registrable Securities (it being understood that the Holders of the Registrable Securities that are to be distributed by any underwriters shall be parties to any such underwriting agreement and may, at their option, require that the Company make to and for the benefit of such Holders the representations, warranties and covenants of the Company which are being made to and for the benefit of such underwriters);
    

    
         
    

    
    
        
            10
            
        

    

    
         

    

    
    
         
    

    
        (j)          
        in connection with an underwritten offering, shall obtain an opinion from the Company’s counsel and a “cold comfort” letter from the Company’s independent public accountants in customary form and covering such matters as are customarily covered by such opinions and “cold comfort” letters delivered to underwriters in underwritten public offerings, which opinion and letter shall be reasonably satisfactory to the underwriter, if any;
    

    
         
    

    
        (k)         
        shall use commercially reasonable efforts to obtain the withdrawal of any order suspending the effectiveness of the Registration Statement;
    

    
         
    

    
        (l)          
        shall provide a CUSIP number for all Registrable Securities, not later than the effective date of the Registration Statement;
    

    
         
    

    
        (m)        
        shall make reasonably available its employees and personnel for participation in “road shows” and other marketing efforts and otherwise provide reasonable assistance to the underwriters, taking into account the needs of the Company’s businesses and the requirements of the marketing process, in the marketing of Registrable Securities in any underwritten offering;
    

    
         
    

    
        (n)         
        shall promptly prior to the filing of any document that is to be incorporated by reference into the Registration Statement or the Prospectus, and prior to the filing of any Issuer Free Writing Prospectus, provide copies of such document to counsel for the selling holders of Registrable Securities and to each managing underwriter, if any, and make the Company’s representatives reasonably available for discussion of such document and make such changes in such document concerning the selling holders prior to the filing thereof as counsel for such selling holders or underwriters may reasonably request;
    

    
         
    

    
        (o)         
        shall cooperate with the sellers of Registrable Securities and the managing underwriter, if any, to facilitate the timely preparation and delivery of certificates not bearing any restrictive legends representing the Registrable Securities to be sold, and cause such Registrable Securities to be issued in such denominations and registered in such names in accordance with the underwriting agreement prior to any sale of Registrable Securities to the underwriters or, if not an underwritten offering, in accordance with the instructions of the sellers of Registrable Securities at least three Business Days prior to any sale of Registrable Securities and instruct any transfer agent and registrar of Registrable Securities to release any stop transfer orders in respect thereof;
    

    
         
    

    
        (p)         
        shall take all such other commercially reasonable actions as are necessary or advisable in order to expedite or facilitate the disposition of such Registrable Securities;
    

    
         
    

    
        (q)         
        shall not take any direct or indirect action prohibited by Regulation M under the Exchange Act; provided, however, that to the extent that any prohibition is applicable to the Company, the Company will take such action as is necessary to make any such prohibition inapplicable;
    

    
         
    

    
        (r)          
        shall cooperate with each seller of Registrable Securities and each underwriter or agent participating in the disposition of such Registrable Securities and their respective counsel in connection with any filings required to be made with FINRA; and
    

    
         
    

    
    
        
            11
            
        

    

    
         

    

    
    
         
    

    
        (s)         
        shall take all reasonable action to ensure that any Issuer Free Writing Prospectus utilized in connection with any registration covered by Section 2.1 or 2.2 complies in all material respects with the Securities Act, is filed in accordance with the Securities Act to the extent required thereby, is retained in accordance with the Securities Act to the extent required thereby and, when taken together with the related prospectus, will not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading.
    

    
         
    

    
        If the Company files any shelf Registration Statement for the benefit of the holders of any of its securities other than the Holders, the Company shall include in such Registration Statement such disclosures as may be required by Rule 430B under the Securities Act, referring to the unnamed selling security holders in a generic manner by identifying the initial offering of the securities to the Holders, in order to ensure that the Holders may be added to such shelf Registration Statement at a later time through the filing of a prospectus supplement rather than a post-effective amendment.
    

    
         
    

    
        The Company may require as a condition precedent to the Company’s obligations under this Section 2.4 that each seller of Registrable Securities as to which any registration is being effected furnish the Company such information in writing regarding such seller and the distribution of such Registrable Securities as the Company from time to time reasonably may request; provided, that such information is necessary for the Company to consummate such registration and shall be used only in connection with such registration.
    

    
         
    

    
        Each seller of Registrable Securities agrees that upon receipt of any notice from the Company under Section 2.4(e)(v), such seller will discontinue such seller’s disposition of Registrable Securities pursuant to the Registration Statement covering such Registrable Securities until such seller’s receipt of the copies of the supplemented or amended Prospectus. In the event the Company shall give any such notice, the applicable period set forth in Section 2.4(b) shall be extended by the number of days during such period from and including the date of the giving of such notice to and including the date when each seller of any Registrable Securities covered by such Registration Statement shall have received the copies of the supplemented or amended Prospectus.
    

    
         
    

    
        If any such Registration Statement or comparable statement under “blue sky” laws refers to any Holder by name or otherwise as the Holder of any securities of the Company, such Holder shall have the right to require (i) the insertion therein of language, in form and substance reasonably satisfactory to such Holder and the Company, to the effect that the holding by such Holder of such securities is not to be construed as a recommendation by such Holder of the investment quality of the Company’s securities covered thereby and that such holding does not imply that such Holder will assist in meeting any future financial requirements of the Company or (ii) in the event that such reference to such Holder by name or otherwise is not in the judgment of the Company, as advised by counsel, required by the Securities Act or any similar federal statute or any state “blue sky” or securities law then in force, the deletion of the reference to such Holder.
    

    
         
    

    
    
        
            12
            
        

    

    
         

    

    
    
         
    

    
        Section 2.5        
        Registration Expenses.
    

    
         
    

    
        (a)           
        The Company shall pay all Registration Expenses (i) with respect to any Demand Registration whether or not it becomes effective or remains effective for the period contemplated by Section 2.4(b) and (ii) with respect to any registration effected under Section 2.2.
    

    
         
    

    
        (b)           
        Notwithstanding the foregoing, (i) the provisions of this Section 2.5 shall be deemed amended to the extent necessary to cause these expense provisions to comply with “blue sky” laws of each state in which the offering is made, (ii) in connection with any registration hereunder, each Holder of Registrable Securities being registered shall pay all underwriting discounts and commissions and any transfer taxes, if any, attributable to the sale of such Registrable Securities, pro rata with respect to payments of discounts and commissions in accordance with the number of Registrable Securities sold in the offering by such Holder and (iii) the Company shall, in the case of all registrations under this Article II, be responsible for all its internal expenses.
    

    
         
    

    
        Section 2.6     
        Underwritten Offerings.
    

    
         
    

    
        (a)           
        In the case of a registration pursuant to Section 2.2, if the Company shall have determined to enter into an underwriting agreement in connection therewith, any Registrable Securities to be included in such registration shall be subject to such underwriting agreement. Any Holder participating in such registration may, at its option, require that any or all of the representations and warranties by, and the other agreements on the part of, the Company to and for the benefit of such underwriters shall also be made to and for the benefit of such Holder and that any or all of the conditions precedent to the obligations of such underwriters under such underwriting agreement be conditions precedent to the obligations of such Holder. No Holder shall be required to make any representations or warranties to or agreements with the Company or the underwriters other than representations, warranties or agreements regarding such Holder, its ownership of and title to the Registrable Securities and its intended method of distribution; and any liability of such Holder to any underwriter or other Person under such underwriting agreement shall be limited to liability arising from breach of its representations and warranties and shall be limited to an amount equal to the proceeds (net of expenses and underwriting discounts and commissions) that it derives from such registration.
    

    
         
    

    
        (b)           
        In the case of a registration under Section 2.2, if the Company has determined to enter into an underwriting agreement in connection therewith, all securities to be included in such registration shall be subject to an underwriting agreement and no Person may participate in such registration unless such Person agrees to sell such Person’s securities on the basis provided therein and, subject to the provisions of this Section 2.6, completes and executes all reasonable questionnaires, and other documents, including custody agreements and powers of attorney, that must be executed in connection therewith, and provides such other information to the Company or the underwriter as may be necessary to register such Person’s securities.
    

    
         
    

    
        Section 2.7     
        Holdback Agreements.
    

    
         
    

    
        (a)           
        Each seller of Registrable Securities agrees, to the extent requested in writing by a managing underwriter, if any, of any registration effected pursuant to Section 2.2, not to (i) lend; offer; pledge; sell; contract to sell; sell any option or contract to purchase; purchase any option or contract to sell; grant any option, right or warrant to purchase; or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any securities convertible into or exercisable or exchangeable (directly or indirectly) for any shares of Common Stock (whether such shares or any such securities are then owned by the Holder or are thereafter acquired) or (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of such securities, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Common Stock or other securities, in cash or otherwise, other than as part of such underwritten public offering during the time period reasonably requested by the managing underwriter, not to exceed 90 days plus such additional period of time as may be required to comply with FINRA Rule 2711 or any similar or successor rules thereto, as such underwriter shall specify reasonably and in good faith.
    

    
         
    

    
    
        
            13
            
        

    

    
         

    

    
    
         
    

    
        (b)           
        The Company agrees that, if it shall previously have received a request for registration pursuant to Section  2.2, and if such previous registration shall not have been withdrawn or abandoned, it shall not sell, transfer or otherwise dispose of any Common Stock, or any other equity security of the Company or any security convertible into or exchangeable or exercisable for any equity security of the Company (other than as part of such underwritten public offering, a registration on Form S-4 or Form S-8 or any successor or similar form which is then in effect or upon the conversion, exchange or exercise of any then outstanding Common Stock Equivalent), until a period of 180 days shall have elapsed from the effective date of such previous registration; and the Company shall so provide in any registration rights agreements hereafter entered into with respect to any of its securities.
    

    
         
    

    
        Section 2.8     
        No Required Sale. Nothing in this Agreement shall be deemed to create an independent obligation on the part of any Holder to sell any Registrable Securities pursuant to any effective registration statement.
    

    
         
    

    
        Section 2.9     
        Indemnification.
    

    
         
    

    
        (a)           
        In the event of any registration of any securities of the Company under the Securities Act pursuant to this Article II, the Company will, and hereby agrees to, indemnify and hold harmless, to the fullest extent permitted by law, each Holder of Registrable Securities, its directors, officers, fiduciaries, employees, agents, affiliates, consultants, representatives, general and limited partners, stockholders, successors, assigns (and the directors, officers, employees and stockholders thereof), and each other Person, if any, who controls such Holder within the meaning of the Securities Act, from and against any and all losses, claims, damages or liabilities, joint or several, actions or proceedings (whether commenced or threatened) and expenses (including reasonable fees of counsel and any amounts paid in any settlement effected with the Company’s consent, which consent shall not be unreasonably withheld or delayed) to which each such indemnified party may become subject under the Securities Act or otherwise in respect thereof (collectively, “Losses”), insofar as such Losses arise out of or are based upon (i) any untrue statement or alleged untrue statement of a material fact contained in any Registration Statement under which such securities were registered under the Securities Act or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading or (ii) any untrue statement or alleged untrue statement of a material fact contained in any preliminary, final or summary Prospectus or any amendment or supplement thereto, together with the documents incorporated by reference therein, or any Issuer Free Writing Prospectus utilized in connection therewith, or the omission or alleged omission to state therein a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading, and the Company will reimburse any such indemnified party for any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such Loss as such expenses are incurred; provided, however, that the Company shall not be liable (i) to any such indemnified party in any such case to the extent such Loss arises out of or is based upon any untrue statement or alleged untrue statement of a material fact or omission or alleged omission of a material fact made in such Registration Statement or amendment thereof or supplement thereto or in any such prospectus or any preliminary, final or summary Prospectus or Issuer Free Writing Prospectus in reliance upon and in conformity with written information furnished to the Company by or on behalf of such indemnified party specifically for use therein, (ii) for any failure of a Holder to deliver a Prospectus, to the extent that such Holder was required to do so under applicable securities laws, or (iii) for the use by such Holder of an outdated or defective Prospectus after the Company has notified such Holder in writing that the Prospectus is outdated or defective. Such indemnity and reimbursement of expenses shall remain in full force and effect regardless of any investigation made by or on behalf of such indemnified party and shall survive the transfer of such securities by such Holder.
    

    
         
    

    
    
        
            14
            
        

    

    
         

    

    
    
         
    

    
        (b)           
        Each Holder of Registrable Securities that are included in the securities as to which any registration under Section 2.1 or 2.2 is being effected shall, severally and not jointly, indemnify and hold harmless (in the same manner and to the same extent as set forth in paragraph (a) of this Section 2.9) to the extent permitted by law the Company, its officers and directors, each Person controlling the Company within the meaning of the Securities Act and all other prospective sellers and their respective directors, officers, fiduciaries, employees, agents, affiliates, consultants, representatives, general and limited partners, stockholders, successors, assigns and respective controlling Persons with respect to any untrue statement or alleged untrue statement of any material fact in, or omission or alleged omission of any material fact from, such Registration Statement, any preliminary, final or summary Prospectus contained therein, or any amendment or supplement thereto, or any Issuer Free Writing Prospectus utilized in connection therewith, if such statement or alleged statement or omission or alleged omission was made in reliance upon and in conformity with written information furnished to the Company or its representatives by or on behalf of such Holder specifically for use therein and reimburse such indemnified party for any legal or other expenses reasonably incurred in connection with investigating or defending any such Loss as such expenses are incurred; provided, however, that the aggregate amount that any such Holder shall be required to pay pursuant to this Section 2.9(b) and Sections 2.9(c), (e) and (f) shall in no case be greater than the amount of the net proceeds received by such Holder upon the sale of the Registrable Securities pursuant to the Registration Statement giving rise to such claim, except in the case of fraud or willful misconduct by such Holder. Such indemnity and reimbursement of expenses shall remain in full force and effect regardless of any investigation made by or on behalf of such indemnified party and shall survive the transfer of such securities by such Holder.
    

    
         
    

    
    
        
            15
            
        

    

    
         

    

    
    
         
    

    
        (c)           
        Any Person entitled to indemnification under this Agreement promptly shall notify the indemnifying party in writing of the commencement of any action or proceeding with respect to which a claim for indemnification may be made pursuant to this Section 2.9, but the failure of any such Person to provide such notice shall not relieve the indemnifying party of its obligations under the preceding paragraphs of this Section 2.9, except to the extent the indemnifying party is materially prejudiced thereby and shall not relieve the indemnifying party from any liability that it may have to any such Person otherwise than under this Article II. In case any action or proceeding is brought against an indemnified party and it shall notify the indemnifying party of the commencement thereof, the indemnifying party shall be entitled to participate therein and, unless in the reasonable opinion of outside counsel to the indemnified party a conflict of interest between such indemnified and indemnifying parties may exist in respect of such claim, to assume the defense thereof jointly with any other indemnifying party similarly notified, to the extent that it chooses, with counsel reasonably satisfactory to such indemnified party, and after notice from the indemnifying party to such indemnified party that it so chooses, the indemnifying party shall not be liable to such indemnified party for any legal or other expenses subsequently incurred by such indemnified party in connection with the defense thereof other than reasonable costs of investigation; provided, however, that (i) if the indemnifying party fails to take reasonable steps necessary to defend diligently the action or proceeding within 20 days after receiving notice from such indemnified party, (ii) if such indemnified party who is a defendant in any action or proceeding that is also brought against the indemnifying party reasonably shall have concluded that there may be one or more legal defenses available to such indemnified party that are not available to the indemnifying party or (iii) if representation of both parties by the same counsel is otherwise inappropriate under applicable standards of professional conduct, then, in any such case, the indemnified party shall have the right to assume or continue its own defense as set forth above (but with no more than one firm of counsel for all indemnified parties in each jurisdiction, except to the extent any indemnified party or parties reasonably shall have concluded that there may be legal defenses available to such party or parties that are not available to the other indemnified parties or to the extent representation of all indemnified parties by the same counsel is otherwise inappropriate under applicable standards of professional conduct) and the indemnifying party shall be liable for any expenses therefor. Without the written consent of the indemnified party, which consent shall not be unreasonably withheld, no indemnifying party shall effect the settlement or compromise of, or consent to the entry of any judgment with respect to, any pending or threatened action or claim in respect of which indemnification or contribution may be sought hereunder, whether or not the indemnified party is an actual or potential party to such action or claim, unless such settlement, compromise or judgment (A) includes an unconditional release of the indemnified party from all liability arising out of such action or claim and (B) does not include a statement as to or an admission of fault, culpability or a failure to act, by or on behalf of any indemnified party.
    

    
         
    

    
    
        
            16
            
        

    

    
         

    

    
    
         
    

    
        (d)           
        If for any reason the foregoing indemnity is unavailable or is insufficient to hold harmless an indemnified party under Section 2.9(a), (b) or (c), then each indemnifying party shall contribute to the amount paid or payable by such indemnified party as a result of any Loss in such proportion as is appropriate to reflect the relative fault of the indemnifying party, on the one hand, and the indemnified party, on the other hand, with respect to such offering of securities. The relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the indemnifying party or the indemnified party and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such untrue statement or omission. If, however, the allocation provided in the second preceding sentence is not permitted by applicable law, then each indemnifying party shall contribute to the amount paid or payable by such indemnified party in such proportion as is appropriate to reflect not only such relative faults but also the relative benefits of the indemnifying party and the indemnified party as well as any other relevant equitable considerations. The parties hereto agree that it would not be just and equitable if contributions pursuant to this Section 2.9(d) were to be determined by pro rata allocation or by any other method of allocation which does not take account of the equitable considerations referred to in the preceding sentences of this Section 2.9(d). The amount paid or payable in respect of any Loss shall be deemed to include any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such Loss. No Person guilty of fraudulent misrepresentation within the meaning of Section 11(f) of the Securities Act shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation. Notwithstanding anything in this Section 2.9(d) to the contrary, no indemnifying party other than the Company shall be required pursuant to this Section 2.9(d) to contribute any amount in excess of the net proceeds received by such indemnifying party from the sale of Registrable Securities in the offering to which the losses, claims, damages or liabilities of the indemnified parties relate, less the amount of any indemnification payment made by such indemnifying party pursuant to Sections 2.9(b) and (c).
    

    
         
    

    
        (e)           
        The indemnity and contribution agreements contained herein shall be in addition to any other rights to indemnification or contribution which any indemnified party may have pursuant to law or contract and shall remain operative and in full force and effect regardless of any investigation made or omitted by or on behalf of any indemnified party and shall survive the transfer of the Registrable Securities by any such party.
    

    
         
    

    
        (f)            
        The indemnification and contribution required by this Section 2.9 shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received or expense, loss, damage or liability is incurred.
    

    
         
    

    
        Article III
        
            
 GENERAL
    

    
         
    

    
        Section 3.1     
        Rule 144. The Company covenants that (a) it will timely file the reports required to be filed by it under the Securities Act or the Exchange Act or, if it is not required to file such reports, upon the request of any Holder it shall make publicly available other information so long as necessary to permit sales of such Registrable Securities in compliance with Rule 144 under the Securities Act and (b) it will take such further action as any Holder of Registrable Securities reasonably may request, all to the extent required from time to time to enable such Holder to sell Registrable Securities without registration under the Securities Act within the limitation of the exemptions provided by (i) Rule 144 under the Securities Act, as such Rule may be amended from time to time, or (ii) any similar rule or regulation hereafter adopted by the SEC. Upon the request of any Holder of Registrable Securities, the Company will deliver to such Holder a written statement as to whether it has complied with such requirements.
    

    
         
    

    
    
        
            17
            
        

    

    
         

    

    
    
         
    

    
        Section 3.2     
        Nominees for Beneficial Owners. If Registrable Securities are held by a nominee for the beneficial owner thereof, the beneficial owner thereof may, at its option, be treated as the Holder of such Registrable Securities for purposes of any request or other action by any Holder or Holders of Registrable Securities pursuant to this Agreement or any determination of any number or percentage of shares constituting Registrable Securities held by any Holder or Holders of Registrable Securities contemplated by this Agreement; provided, that the Company shall have received assurances reasonably satisfactory to it of such beneficial ownership.
    

    
         
    

    
        Section 3.3     
        No Inconsistent Agreements. The rights granted to the Holders of Registrable Securities hereunder do not in any way conflict with and are not inconsistent with any other agreements to which the Company is a party or by which it is bound.
    

    
         
    

    
        Article IV
        
            
 MISCELLANEOUS
    

    
         
    

    
        Section 4.1     
        Amendment; Waiver and Termination.
    

    
         
    

    
        (a)           
        Any provision of this Agreement may be amended or waived if, and only if, such amendment or waiver is in writing and is signed, in the case of an amendment, by the Company and Holders of a majority of the then outstanding Registrable Securities or, in the case of a waiver, by the party or parties against whom the waiver is to be effective, in an instrument specifically designated as an amendment or waiver hereto; provided, however, that waiver by the Holders shall require the consent of Holders of a majority of the then outstanding Registrable Securities.
    

    
         
    

    
        (b)           
        No failure or delay of any party in exercising any right or remedy hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such right or power, or any abandonment or discontinuance of steps to enforce such right or power, or any course of conduct, preclude any other or further exercise thereof or the exercise of any other right or power. The rights and remedies of the parties hereunder are cumulative and are not exclusive of any rights or remedies which they would otherwise have hereunder.
    

    
         
    

    
        (c)           
        The rights to request registration or inclusion of Registrable Securities in any registration pursuant to the terms of this Agreement shall terminate upon the expiration of the Effectiveness Period.
    

    
         
    

    
        Section 4.2     
        Notices. All notices and other communications hereunder shall be in writing and shall be deemed duly given (a) on the date of delivery if delivered personally, or if by facsimile or e-mail, upon written confirmation of receipt sent by the recipient via facsimile, e-mail or otherwise, (b) on the first Business Day following the date of dispatch if delivered utilizing a next-day service by a recognized next-day courier or (c) on the earlier of confirmed receipt or the fifth Business Day following the date of mailing if delivered by registered or certified mail, return receipt requested, postage prepaid. All notices hereunder shall be delivered to the addresses set forth below, or pursuant to such other instructions as may be designated in writing by the party to receive such notice:
    

    
         
    

    
    
        
            18
            
        

    

    
         

    

    
    
         
    

    
        (i)        
        if to any Holder other than the Original Holder, to its last known address appearing on the books of the Company maintained for such purpose, and if to the Original Holder, to:
    

    
         
    

    
        932 Southwood Boulevard
            
 Incline Village, NV 89451
            
 Attention: General Counsel
            
 Telephone: (775) 832-8500
            
 Facsimile: (775) 832-8501
    

    
         
    

    
        with a copy (which shall not constitute notice) to:
    

    
         
    

    
        Karen E. Bertero
            
 Gibson Dunn & Crutcher LLP
            
 333 South Grand Avenue, Los Angeles, CA 90071-3197
            
 Telephone: (213) 229-7360
            
 Facsimile: (213) 229-7888
            
 Email: KBertero@gibsondunn.com
    

    
         
    

    
        (ii)        
        if to the Company, to:
    

    
         
    

    
        405 State Highway 121
            
 Suite B-240
            
 Lewisville, Texas 75067
            
 Attention: General Counsel
            
 Telephone: (972) 943-6050
            

            

        
    

    
         
    

    
        with a copy (which shall not constitute notice) to:
    

    
         
    

    
        Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
            
 One Financial Center, Boston, MA 02111
            
 Attention: Meryl Epstein
            
 Telephone: (617) 348-1635
            
 Facsimile: (617) 542-2241
            
 E-mail: MJEpstein@mintz.com
    

    
         
    

    
        or such other address as the Company or the Original Holder shall have specified to the other party in writing in accordance with this Section 4.2.
    

    
         
    

    
        Section 4.3     
        Interpretation. When a reference is made in this Agreement to a Section or Article, such reference shall be to a Section or Article of this Agreement unless otherwise indicated. The headings contained in this Agreement are for convenience of reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. All words used in this Agreement will be construed to be of such gender or number as the circumstances require. The word “including” and words of similar import when used in this Agreement will mean “including, without limitation,” unless otherwise specified. The words “hereof,” “herein” and “hereunder” and words of similar import when used in this Agreement shall refer to the Agreement as a whole and not to any particular provision in this Agreement. The term “or” is not exclusive. The word “will” shall be construed to have the same meaning and effect as the word “shall.” References to days mean calendar days unless otherwise specified.
    

    
         
    

    
    
        
            19
            
        

    

    
         

    

    
    
         
    

    
        Section 4.4     
        Entire Agreement. This Agreement, the Warrant, the Credit Agreement and the Modification Agreement constitute the entire agreement, and supersede all prior written agreements, arrangements, communications and understandings and all prior and contemporaneous oral agreements, arrangements, communications and understandings between the parties with respect to the subject matter hereof and thereof.
    

    
         
    

    
        Section 4.5     
        No Third-Party Beneficiaries. Except as provided in Section 2.9, nothing in this Agreement, express or implied, is intended to or shall confer upon any Person other than the parties and their respective successors and permitted assigns any legal or equitable right, benefit or remedy of any nature under or by reason of this Agreement.
    

    
         
    

    
        Section 4.6     
        Governing Law. This Agreement and all disputes or controversies arising out of or relating to this Agreement or the transactions contemplated hereby shall be governed by, and construed in accordance with, the internal laws of the State of New York, without regard to the laws of any other jurisdiction that might be applied because of the conflicts of laws principles of the State of New York.
    

    
         
    

    
        Section 4.7     
        Submission to Jurisdiction. Each of the parties irrevocably agrees that any legal action or proceeding arising out of or relating to this Agreement brought by the other party or its successors or assigns shall be brought and determined in any New York State or federal court sitting in the Borough of Manhattan in The City of New York (or, if such court lacks subject matter jurisdiction, in any appropriate New York State or federal court), and each of the parties hereby irrevocably submits to the exclusive jurisdiction of the aforesaid courts for itself and with respect to its property, generally and unconditionally, with regard to any such action or proceeding arising out of or relating to this Agreement and the transactions contemplated hereby. Each of the parties agrees not to commence any action, suit or proceeding relating thereto except in the courts described above in New York, other than actions in any court of competent jurisdiction to enforce any judgment, decree or award rendered by any such court in New York as described herein. Each of the parties further agrees that notice as provided herein shall constitute sufficient service of process and the parties further waive any argument that such service is insufficient. Each of the parties hereby irrevocably and unconditionally waives, and agrees not to assert, by way of motion or as a defense, counterclaim or otherwise, in any action or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby, (a) any claim that it is not personally subject to the jurisdiction of the courts in New York as described herein for any reason, (b) that it or its property is exempt or immune from jurisdiction of any such court or from any legal process commenced in such courts (whether through service of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise) and (c) that (i) the suit, action or proceeding in any such court is brought in an inconvenient forum, (ii) the venue of such suit, action or proceeding is improper or (iii) this Agreement, or the subject matter hereof, may not be enforced in or by such courts.
    

    
         
    

    
        Section 4.8     
        Assignment; Successors. This Agreement will be binding upon, inure to the benefit of, and be enforceable by, the parties and their respective successors and assigns. If any Person shall acquire Registrable Securities from any Holder in any manner, whether by operation of law or otherwise, such Person shall promptly notify the Company and such Registrable Securities acquired from such Holder shall be held subject to all of the terms of this Agreement, and by taking and holding such Registrable Securities such Person shall be entitled to receive the benefits of and be conclusively deemed to have agreed to be bound by and to perform all of the terms and provisions of this Agreement. Any such successor or assign shall agree in writing to acquire and hold the Registrable Securities acquired from such Holder subject to all of the terms hereof. If any Holder shall acquire additional Registrable Securities, such Registrable Securities shall be subject to all of the terms, and entitled to all of the benefits, of this Agreement.
    

    
         
    

    
    
        
            20
            
        

    

    
         

    

    
    
         
    

    
        Section 4.9        
        Enforcement. The parties agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. Accordingly, each of the parties shall be entitled to specific performance of the terms hereof, including an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in any New York State or federal court sitting in the Borough of Manhattan in The City of New York (or, if such court lacks subject matter jurisdiction, in any appropriate New York State or federal court), this being in addition to any other remedy to which such party is entitled at law or in equity. Each of the parties hereby further waives (a) any defense in any action for specific performance that a remedy at law would be adequate and (b) any requirement under any law to post security as a prerequisite to obtaining equitable relief.
    

    
         
    

    
        Section 4.10      
        Severability. Whenever possible, each provision or portion of any provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision or portion of any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability shall not affect any other provision or portion of any provision in such jurisdiction, and this Agreement shall be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision or portion of any provision had never been contained herein.
    

    
         
    

    
        Section 4.11     
        Waiver of Jury Trial. EACH OF THE PARTIES TO THIS AGREEMENT HEREBY IRREVOCABLY WAIVES ALL RIGHT TO A TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.
    

    
         
    

    
        Section 4.12    
         Counterparts. This Agreement may be executed in two or more counterparts, all of which shall be considered one and the same instrument and shall become effective when one or more counterparts have been signed by each of the parties and delivered to the other parties.
    

    
         
    

    
        Section 4.13      
        Facsimile or .pdf Signature. This Agreement may be executed by facsimile or .pdf signature and a facsimile or .pdf signature shall constitute an original for all purposes
    

    
         
    

    
        Section 4.14      
        Time of Essence. Time is of the essence with regard to all dates and time periods set forth or referred to in this Agreement.
    

    
         
    

    
    
        
            21
            
        

    

    
         

    

    
    
         
    

    
        Section 4.15     
        No Presumption Against Drafting Party. Each of the parties hereto acknowledges that it has been represented by counsel in connection with this Agreement and the transactions contemplated by this Agreement. Accordingly, any rule of law or any legal decision that would require interpretation of any claimed ambiguities in this Agreement against the drafting party has no application and is expressly waived.
    

    
         
    

    
        [The remainder of this page is intentionally left blank.]
    

    
         
    

    
    
        
            22
            
        

    

    
         

    

    
    
         
    

    
        IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.
    

    
         
    

    
         
    

    	
                 
            	
                CAREVIEW COMMUNICATIONS, INC.
                , a Nevada corporation,
            
	
                 
            	
                 
            	
                 
            
	
                 
            	
                By:
            	
                /s/ Steven G. Johnson
            
	
                 
            	
                Name: Steven G. Johnson
            
	
                 
            	
                Title: President and Chief Executive Officer
            

    
          
    

    
        Signature Page to Amended and Restated Registration Rights Agreement
             
        
    

    
         
    

    
    
        

    

    
         

    

    
    
         
    

    
         
    

    	
                 
            	
                PDL INVESTMENT HOLDINGS, LLC 
                a Delaware limited liability company
            
	
                 
            	
                 
            	
                 
            
	
                 
            	
                By:
            	
                /s/ Steffen Pietzke
            
	
                 
            	
                Name: Steffen Pietzke
            
	
                 
            	
                Title: CEO
            

    
         
    

    
        Signature Page to Amended and Restated Registration Rights Agreementex10-4.htm

    
    
         

    

    CareView Communications, Inc. 8-K

    Exhibit 10.4

     

    CONSENT AND AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT AND SUBORDINATION AND INTERCREDITOR AGREEMENT

     

    CONSENT AND AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT AND SUBORDINATION AND INTERCREDITOR AGREEMENT (this “Consent and Amendment”), dated as of February 2, 2018, among CAREVIEW COMMUNICATIONS, INC., a Nevada corporation (“Holdings”), CAREVIEW COMMUNICATIONS, INC., a Texas corporation and a wholly-owned subsidiary of Holdings (the “Borrower”), PDL INVESTMENT HOLDINGS, LLC, a Delaware limited liability company (as assignee of PDL BioPharma, Inc.), in its capacity as lender under the Credit Agreement defined below (in such capacity, the “Lender”) and in its capacity as agent (in such capacity, the “Agent”) under the Credit Agreement defined below, and EACH OF THE NOTE INVESTORS SIGNATORY TO THAT CERTAIN NOTE AND WARRANT PURCHASE AGREEMENT DEFINED BELOW (the “Note Investors”).

     

    W I T N E S S E T H

     

    WHEREAS Holdings, the Borrower, the Lender and the Agent have entered into that certain Credit Agreement dated as of June 26, 2015 (as amended, the “Credit Agreement”) pursuant to which the Lender made a term loan to the Borrower in the original aggregate principal amount of $20,000,000;

     

    WHEREAS Holdings and the Note Investors have entered into that certain Note and Warrant Purchase Agreement dated as of April 21, 2011 (as amended, the “NWPA”) pursuant to which Holdings issued to the Note Investors senior secured convertible notes (the “NWPA Notes”) and warrants to purchase Holdings’ common stock (the “NWPA Warrants”);

     

    WHEREAS the Agent and the Note Investors have entered into that certain Subordination and Intercreditor Agreement dated as of June 26, 2015 (the “Intercreditor Agreement”) pursuant to which the Note Investors agreed to the payment and lien subordination of obligations owed to the Note Investors under the NWPA to obligations owed to the Lender and the Agent under the Credit Agreement;

     

    WHEREAS, the Borrower has requested that the Lender agree to modify certain provisions of the Credit Agreement and the other First Lien Loan Documents to prevent Events of Default from occurring thereunder during a defined “Modification Period” on the terms set forth in the Modification Agreement dated as of the date hereof among Holdings, the Borrower, the Subsidiary Guarantor, the Lender and the Agent (the “Modification Agreement”); and

     

    WHEREAS in order to induce the Lender to enter into the Modification Agreement, and in order to further the purposes of the Modification Agreement and the transactions contemplated thereby, the Note Investors are willing to agree to the consents in respect of the terms of the NWPA and amendment to the Intercreditor Agreement as set forth herein.

     

    
    
          

    

    
         

    

    
     

    NOW, THEREFORE, in consideration of the agreements hereinafter set forth, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the parties hereto agree as follows:

     

    
        Article I.
        
 DEFINITIONS

     

    
        1.1
                     
        Definitions. Unless otherwise defined herein or the context otherwise requires, terms used in this Amendment, including its preamble and recitals, have the meanings provided in the Intercreditor Agreement.

     

    
        Article II.
        
 AMENDMENT TO INTERCREDITOR AGREEMENT

     

    
        2.1         Amendment to Section 5.1(b). Subject to Section 4.1 of this Consent and Amendment, Section 5.1(b) of the Intercreditor Agreement is hereby amended and restated in its entirety as follows:

     

    “(b)       If in connection with any sale, lease, exchange, transfer or other disposition of any Collateral (collectively, a “Disposition”) permitted under the terms of both the First Lien Loan Documents and the Second Lien Loan Documents (other than in connection with the exercise of PDL’s remedies in respect of the Collateral provided for by the First Lien Loan Documents), PDL releases for itself or on behalf of any of the First Lien Claimholders any of its Liens on any part of the Collateral or releases any Grantor from its guaranty of the First Lien Obligations in connection with the sale of the stock, or substantially all the assets, of the Borrower or the applicable Grantor other than (A) in connection with the Discharge of First Lien Obligations and (B) after the occurrence and during the continuance of any Event of Default under the Note Purchase Agreement, then the Liens, if any, of the Second Lien Claimholders on such Collateral and the obligations of such Grantor under its guaranty of the Second Lien Obligations shall be automatically, unconditionally and simultaneously released; provided that the net proceeds from any Disposition are applied to repay Obligations under the Credit Agreement to the extent required thereby. The foregoing notwithstanding, in the event that PDL consents to any Disposition of all or any portion of the hospital assets of any Grantor that is Collateral (including a sale of any Grantor all or substantially all of the assets of which are hospital assets) (but other than in connection with the exercise of PDL’s remedies in respect of the Collateral provided for by the First Lien Loan Documents) (a “Hospital Disposition”), and PDL releases for itself or on behalf of any of the First Lien Claimholders any of its Liens on any part of such hospital assets that are Collateral or releases any Grantor from its guaranty of the First Lien Obligations in connection with a Hospital Disposition, then the Liens, if any, of the Second Lien Claimholders on such hospital assets and the obligations of any such Grantor under its guaranty of the Second Lien Obligations shall be automatically, unconditionally and simultaneously released; provided that the net proceeds from any Hospital Disposition are applied to repay first, Obligations under the Credit Agreement until paid in full and thereafter, the Second Lien Obligations. The Second Lien Claimholders shall promptly execute and deliver to PDL, the Borrower or the applicable Grantor such termination statements, releases and other documents as PDL, the Borrower or the applicable Grantor may reasonably request to effectively confirm any such release contemplated herein.”

     

    
    
        
            2
        

    

    
         

    

    
     

    
        Article III.
        
 CONSENTS TO NOTE AND WARRANT PURCHASE AGREEMENT

     

    
        3.1
                     
        Consent under Sections 5.4 and 6.12. Subject to Section 4.1 of this Consent and Amendment, the Note Investors agree that the right of each Note Investor to purchase New Securities pursuant to Section 5.4 of the NWPA and the requirement that the Note Investors provide prior written consent prior to the issuance of capital stock or securities convertible into capital stock shall not apply to any issuance of capital stock or indebtedness pursuant to Section 5(a) and 5(d) of the Modification Agreement.

     

    
        3.2
                     
        Consent under Section 6.4. For the avoidance of doubt, and subject to Section 4.1 of this Consent and Amendment, the Note Investors agree that any cash payment required to be made to PDL pursuant to Section 5(f)(ii) of the Modification Agreement shall be “First Lien Obligations”, and no payment of First Lien Obligations (including First Lien Obligations paid pursuant to Section 5(f)(ii) of the Modification Agreement) shall result in a violation of Section 6.4 of the NWPA.

     

    
        Article IV.
        
 condition

     

    
        4.1
                     
        Condition Precedent. The effectiveness of this Consent and Amendment shall be conditioned upon the execution and delivery of the Modification Agreement among Holdings, the Borrower, the Subsidiary Guarantor, Agent and Lender, and delivery of a copy thereof to the Second Lien Agent, in each case on or prior to February 2, 2018.

     

    
        Article V.
        
 MISCELLANEOUS

     

    
        5.1
                     
        Representation and Warranty regarding Note Investors. Holdings and the Borrower hereby represent and warrant to the Lender that the Note Investors executing this Consent and Amendment constitute all Note Investors who as of the date hereof hold shares of common stock of Holdings issued or issuable upon conversion of the NWPA Notes and the exercise of the NWPA Warrants. Holdings and the Borrower agree that any inaccuracy in the foregoing representation and warranty shall constitute an automatic Event of Default under the Credit Agreement.

     

    
        5.2
                     
        Reaffirmation of Intercreditor Agreement. Each of Agent and the Note Investors party hereto hereby acknowledges and reaffirms its respective obligations, duties and covenants under the Intercreditor Agreement, as modified hereby.

     

    
        5.3
                     
        Counterparts. This Consent and Amendment may be executed by the parties hereto in several counterparts, each of which shall be deemed to be an original and all of which shall constitute together but one and the same agreement. Delivery of an executed signature page of this Consent and Amendment by facsimile transmission or electronic transmission shall be as effective as delivery of a manually executed counterpart hereof.

     

    
    
        
            3
        

    

    
         

    

    
     

    
        5.4
                     
        Construction; Captions. Each party hereto hereby acknowledges that all parties hereto participated equally in the negotiation and drafting of this Consent and Amendment and that, accordingly, no court construing this Consent and Amendment shall construe it more stringently against one party than against the other. The captions and headings of this Consent and Amendment are for convenience of reference only and shall not affect the interpretation of this Consent and Amendment. This Consent and Amendment shall, unless otherwise expressly indicated herein, be construed, administered and applied in accordance with the terms and provisions of the Intercreditor Agreement.

     

    
        5.5
                     
        Successors and Assigns. This Consent and Amendment shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns (as permitted under the Credit Agreement and the Intercreditor Agreement).

     

    
        5.6
                     
        
        Governing Law. 
        This CONSENT AND Amendment, the rights and obligations of the parties hereto, and any claims or disputes relating thereto shall be governed by and construed in accordance with THE INTERNAL LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO CONFLICT OF LAWS PRINCIPLES (OTHER THAN SECTION 5-1401 OF THE NEW YORK GENERAL OBLIGATIONS LAW). 
    

     

    
        5.7
                     
        Severability. The illegality or unenforceability of any provision of this Consent and Amendment or any instrument or agreement required hereunder shall not in any way affect or impair the legality or enforceability of the remaining provisions of this Consent and Amendment or any instrument or agreement required hereunder.

     

    [Signature page follows]

     

    
    
        
            4
        

    

    
         

    

    
     

    IN WITNESS WHEREOF, each of the parties hereto has caused this Consent and Amendment to be duly executed and delivered as of the date first above written.

     

    	 	HOLDINGS:
	 	 	 
	 	CAREVIEW COMMUNICATIONS, INC., a Nevada corporation
	 	 	 
	 	By:	/s/ Steven G. Johnson
	 	Name: Steven G. Johnson
	 	Title: President and Chief Executive Officer
	 	 	 
	 	BORROWER:
	 	 	 
	 	CAREVIEW COMMUNICATIONS, INC., a Texas corporation
	 	 	 
	 	By:	/s/ Steven G. Johnson
	 	Name: Steven G. Johnson
	 	Title: President and Chief Executive Officer
	 	 	 
	 	LENDER:
	 	 	 
	 	PDL INVESTMENT HOLDINGS, LLC
	 	 	 
	 	By:	/s/ Steffen Pietzke
	 	Name: Steffen Pietzke
	 	Title: CEO
	 	 	 
	 	AGENT:
	 	 	 
	 	PDL INVESTMENT HOLDINGS, LLC
	 	 	 
	 	By:	/s/ Steffen Pietzke
	 	Name: Steffen Pietzke
	 	Title: CEO

     

    [Signature Page to Consent and Amendment]

     

    
    
          

    

    
         

    

    
    

     

	 	NOTE INVESTORS:
	 	 
	 	HealthCor Partners Fund, L.P.
	 	By:  HealthCor Partners Management L.P., as Manager
	 	By:  HealthCor Partners Management, G.P., LLC, as General Partner
	 	 
	 	 
	 	By: 	/s/ Jeffrey C. Lightcap
	 	Name:  Jeffrey C. Lightcap
	 	Title:  Senior Managing Director
	 	 
	 	 
	 	Address:	HealthCor Partners
	 	 	1325 Avenue of the Americas, 27th Floor
	 	 	New York, NY 10019
	 	 
	 	 
	 	HealthCor Hybrid Offshore Master Fund, L.P.
	 	By:  HealthCor Hybrid Offshore G.P., LLC, as General Partner
	 	 
	 	 
	 	By: 	/s/ Joseph Healey
	 	Name:  Joseph Healey
	 	Title:  
	 	 
	 	Address:	HealthCor Partners
	 	 	Carnegie Hall Towers
	 	 	152 West 57th Street
	 	 	New York, NY 10019

 

 

[Signature Page to Consent and Amendment]

 

    	 

    	 

    

	 	NOTE INVESTORS:
	 	 
	 	 
	 	 
	 	/s/ Allen Wheeler
	 	Allen Wheeler
	 	 
	 	 
	 	 
	 	/s/ Steven Johnson
	 	Steven Johnson
	 	 
	 	 
	 	 
	 	/s/ James R. Higgins
	 	Dr. James R. Higgins

 

 

[Signature Page to Consent and Amendment]

 

    	 

    	 

    

	 	NOTE INVESTORS:
	 	 
	 	Raymond James & Assoc. Inc., not in its corporate capacity but solely as Custodian of the Individual Retirement Account of Sandra K. McRee.  Further, all representations, warranties and covenants (including indemnities) set forth herein are being made by Sandra K. McRee, not Raymond James & Assoc. Inc.
	 	 
	 	 
	 	By: 	/s/ Joann A. Smith
	 	Name:  Joann Smith
	 	Title:  Custodian
	 	 
	 	 
	 	 
	 	 
	 	/s/ Sandra K. McRee
	 	Sandra K. McRee

 

 

[Signature Page to Consent and Amendment]

 

    	 

    	 

    

	 	NOTE INVESTORS:
	 	 
	 	 
	 	 
	 	/s/ Stephen Berkley
	 	Stephen Berkley
	 	 
	 	 
	 	 
	 	/s/ Alexandra Berkley
	 	Alexandra Berkley
	 	 
	 	 
	 	 
	 	/s/ Steven B. Epstein
	 	Steven B. Epstein
	 	 
	 	 
	 	 
	 	/s/ Deborah L. Epstein
	 	Deborah L. Epstein
	 	 
	 	 
	 	 
	 	/s/ Jason Peter Epstein
	 	Jason Peter Epstein
	 	 
	 	 
	 	 
	 	/s/ Gregory Harris Epstein
	 	Gregory Harris Epstein
	 	 
	 	 
	 	 
	 	/s/ David Epstein
	 	David Epstein
	 	 

 

 

[Signature Page to Consent and Amendment]

 

    	 

    	 

    

	 	NOTE INVESTORS:
	 	 
	 	 
	 	 
	 	 
	 	/s/ Juliann Martin
	 	Juliann Martin
	 	 
	 	 
	 	 
	 	/s/ Jason Thompson
	 	Jason Thompson
	 	 
	 	 
	 	 
	 	Thompson Family Investments, LLC
	 	 
	 	 
	 	 
	 	By: 	/s/ Jason Thompson
	 	Name:  Jason Thompson
	 	Title:  Manager

 

 

[Signature Page to Consent and Amendment]

 

    	 

    	 

    

	 	NOTE INVESTORS:
	 	 
	 	 
	 	 
	 	/s/ Irwin Leiber
	 	Irwin Leiber
	 	 
	 	 
	 	 
	 	/s/ Joseph P. Healey
	 	Joseph P. Healey
	 	 
	 	 
	 	 
	 	/s/ Arthur B. Cohen
	 	Arthur B. Cohen
	 	 
	 	 
	 	 
	 	SJ2, LLC
	 	 
	 	 
	 	 
	 	By: 	/s/ Michael Mashaal
	 	Name:  Michael Mashaal
	 	Title:  Manager
	 	 
	 	 
	 	Joseph Healey F/B/O The Joseph P. Healey 2011
    Family     Trust
	 	 
	 	 
	 	By: 	/s/ Joseph L. Dowling III
	 	Name:  Joseph L. Dowling III
	 	Title:  Trustee

 

 

[Signature Page to Consent and Amendment]

 

    	 

    	 

    

	 	NOTE INVESTORS:
	 	 
	 	PENSCO TRUST COMPANY LLC, not in its corporate capacity but solely as Custodian of the Individual Retirement Account of Jeffrey C. Lightcap
	 	 
	 	 
	 	 
	 	By: 	 
	 	Name:  
	 	Title:  
	 	 
	 	 
	 	/s/ Jeffrey C. Lightcap
	 	Jeffrey C. Lightcap
	 	Beneficial Owner
	 	 
	 	 
	 	Jeffrey C. Lightcap & Jane Lightcap Minor’s Present Interest Trust dated March 20th, 1997 F/B/O Bradford C. Lightcap
	 	 
	 	 
	 	By: 	/s/ Ira L. Schwartz
	 	Name:  Ira L. Schwartz
	 	Title:  Trustee
	 	 
	 	 
	 	Jeffrey C. Lightcap & Jane Lightcap Minor’s Present Interest Trust dated March 20th, 1997 F/B/O Brian R. Lightcap
	 	 
	 	 
	 	By: 	/s/ Ira L. Schwartz
	 	Name:  Ira L. Schwartz
	 	Title:  Trustee
	 	 
	 	 
	 	Jeffrey C. Lightcap & Jane Lightcap Minor’s Present Interest Trust dated March 20th, 1997 F/B/O Megan M. Lightcap
	 	 
	 	 
	 	By: 	/s/ Ira L. Schwartz
	 	Name:  Ira L. Schwartz
	 	Title:  Trustee

 

 

[Signature Page to Consent and Amendment]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00278-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00278-of-00352.parquet"}]]